The Cyborgs Commeth - EP 69 Connor Glass

Phantom Neuro’s subdermal implant offers a practical brain‑computer interface alternative by placing a sensor under the skin of an amputated limb rather than inserting electrodes into the cortex. By tapping into residual muscle activity, the device captures electrical signals that are roughly a thousand times larger than those recorded from the brain, simplifying detection and decoding. This approach sidesteps the high‑risk neurosurgery required by companies like Neuralink, delivering a safer, more scalable solution for prosthetic control and other wearable technologies.

The company has already conducted surface‑sensor trials with dozens of amputees, including a demonstrative test with a user named Alex who lost his forearm. Those non‑implanted studies proved the concept, and the team is now ready to begin its first implantable clinical trial. The procedure is comparable to a routine outpatient task: a local anesthetic injection, a fifteen‑minute insertion, and no specialized neurosurgeon needed. This low‑cost, low‑overhead model could dramatically accelerate adoption, offering amputees a reliable, intuitive way to operate robotic hands such as those from Psionic.

In the broader market, wearable armbands like Meta’s Control Labs acquisition have shown promise but struggle with sweat, movement, and the need for extensive calibration. Surface sensors lose fidelity under real‑world conditions, limiting their utility for industrial or daily tasks where reliability is critical. Phantom Neuro’s implant addresses these shortcomings by providing a stable, high‑signal interface that works without constant recalibration. As biotech conferences like JPM highlight, the shift toward implantable, muscle‑based sensing is poised to redefine human‑machine interaction, moving from experimental demos to everyday prosthetic functionality.